Malabar Cancer Centre
In research, Malabar Cancer Centre stands highest in Medicine (#7,605 of 10,443 worldwide) and Health Sciences (#9,155 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #23,655 of 28,054 · #31,307 all time
- Rank in India
- #1,569 of 1,840
- Research works
- 318 ▲ 63% vs 2013–17
- Citations
- 1.4k 4.3 per fractional work
- Top-10% rate
- 3.0% record average 16.5%
- Open access
- 69% world 28%
What is Malabar Cancer Centre known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #7,605 of 10,443 | 2.2% | 87 | #10604 | |
| Health SciencesDomain | #9,155 of 11,982 | 2.2% | 95 | #13332 |
Each strip is that field’s whole ranked pool, with the notch where Malabar Cancer Centre sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 6.0×. Every wedge is a field page.
- Dentistry 6.0×
- Medicine 3.8×
- Pharmacology, Toxicology and Pharmaceutics 2.4×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Health Professions 1.3×
- Nursing 1.3×
- Chemistry 0.9×
- Physics and Astronomy 0.7×
- Psychology 0.5×
- Business, Management and Accounting 0.4×
- Economics, Econometrics and Finance 0.3×
- Immunology and Microbiology 0.2×
- Agricultural and Biological Sciences 0.1×
- Arts and Humanities 0.1×
- Social Sciences 0.1×
- Environmental Science 0.1×
- Engineering 0.1×
- Computer Science 0.0×
Who are the top researchers at Malabar Cancer Centre?
Ranked on the composite score, Satheesan Balasubramanian lead among researchers whose main affiliation is Malabar Cancer Centre.
- 1 Satheesan Balasubramanian India · #1,086,052 worldwide 6 citations · 16 works
Which keywords describe research at Malabar Cancer Centre?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Radiotherapy, Risk Factors, Prognostic Factors, Clinical Practice Guidelines, Prognosis, Quality of Life and Squamous Cell Carcinoma.
- Population-Based Study
- Mesenchymal Stem Cells
- Anemia
- Preoperative Chemoradiotherapy
- Blood Transfusion
- Metastasis
- Clinical Trials
- Prevention
- Genetic Mutations
- Neoadjuvant Therapy
- Depression
- Breast Cancer
- Oropharyngeal Cancer
- Biomarkers
- Survival
- Cancer
- Prognosis
- Prognostic Factors
- Risk Factors
- Epidemiology
- Chemotherapy
- Radiotherapy
- Quality of Life
- Clinical Practice Guidelines
- Squamous Cell Carcinoma
- Human Papillomavirus
- Cetuximab
- Nasopharyngeal Carcinoma
- Treatment
- Survival Analysis
- Immunotherapy
- Cancer Incidence
- Hematopoietic Stem Cells
- Anxiety
- Health-related Quality of Life
- Surgical Management
- Tumor Markers
- Adjuvant Chemotherapy
- BRAF Mutation
- Thyroid Carcinoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy17▲ 21×15 topics
- Epidemiology10▲ 2.1×27 topics
- Radiotherapy10▲ 21×10 topics
- Risk Factors8▲ 6.2×8 topics
- Quality of Life8▲ 4.5×14 topics
- Prognostic Factors7▲ 14×11 topics
- Clinical Practice Guidelines6▲ 10.0×8 topics
- Prognosis6▲ 16×4 topics
- Squamous Cell Carcinoma6▲ 56×3 topics
- Cancer6▲ 3.5×15 topics
- Human Papillomavirus6▲ 38×3 topics
- Survival6▲ 34×4 topics
- Cetuximab5▲ 53×2 topics
- Biomarkers5▲ 6.1×9 topics
- Nasopharyngeal Carcinoma5▲ 81×1 topic
- Oropharyngeal Cancer5▲ 81×1 topic
- Treatment5▲ 3.3×16 topics
- Breast Cancer4▲ 16×7 topics
- Survival Analysis4▲ 13×6 topics
- Depression4▲ 3.7×6 topics
- Immunotherapy4▲ 4.6×10 topics
- Neoadjuvant Therapy4▲ 14×3 topics
- Cancer Incidence4▲ 23×4 topics
- Genetic Mutations4▲ 7.3×7 topics
- Hematopoietic Stem Cells4▲ 36×3 topics
- Prevention4▲ 7.4×7 topics
- Anxiety4▲ 6.5×5 topics
- Clinical Trials4▲ 4.5×6 topics
- Health-related Quality of Life3▲ 12×2 topics
- Metastasis3▲ 8.1×7 topics
- Surgical Management3▲ 6.7×9 topics
- Blood Transfusion3▲ 58×2 topics
- Tumor Markers3▲ 32×2 topics
- Preoperative Chemoradiotherapy3▲ 31×2 topics
- Adjuvant Chemotherapy3▲ 35×2 topics
- Anemia3▲ 24×2 topics
- BRAF Mutation3▲ 32×2 topics
- Mesenchymal Stem Cells3▲ 21×2 topics
- Thyroid Carcinoma3▲ 45×2 topics
- Population-Based Study3▲ 34×2 topics
Which research topics does Malabar Cancer Centre publish most on?
By volume in 2022–2025: Head and Neck Cancer Studies, Hematopoietic Stem Cell Transplantation, Thyroid Cancer Diagnosis and Treatment and Global Cancer Incidence and Screening.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Head and Neck Cancer Studies Otorhinolaryngology 5 works
- 2 Hematopoietic Stem Cell Transplantation Hematology 2 works
- 3 Thyroid Cancer Diagnosis and Treatment Endocrinology, Diabetes and Metabolism 2 works
- 4 Global Cancer Incidence and Screening Oncology 2 works
- 5 Cancer survivorship and care Oncology 2 works
- 6 Neutropenia and Cancer Infections Oncology 2 works
- 7 Colorectal Cancer Surgical Treatments Oncology 2 works
- 8 Blood transfusion and management Biochemistry 2 works
- 9 Oral Health Pathology and Treatment Periodontics 2 works
- 10 Colorectal Cancer Screening and Detection Oncology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Malabar Cancer Centre's research output changed?
Output in 2018–2022 was 63% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.